In a 64-35 vote, the Senate approved the seventeenth fix to the sustainable growth rate (SGR) payment formula.
In a 64-35 vote, the Senate approved the seventeenth fix to the sustainable growth rate (SGR) payment formula. The decision came only days after the House of Representatives voted in favor of the same “doc fix” bill, which will also delay the mandated implementation of International Classification of Diseases, Tenth Revision (ICD-10) coding and the 2-midnight rule within hospitals for another year.
“I’m pleased that we’ve been able to come to an agreement to vote today on a 12-month fix to the Medicare physician payment system. We need to take action on this to ensure that Medicare patients will be able to see their doctors,” Senate Majority Leader Harry Reid said Monday in a speech on the Senate floor. “But the fact remains that the agreement we have in place is not ideal… regrettably, we just don’t have the votes right now to fix this problem for good.”
Industry experts predicted the bill would pass through the Senate, despite opposition from many physician groups. Physician group representatives said they would be willing to accept a 24% cut in Medicare reimbursement payments if it would result in a permanent repeal of the highly contested SGR formula. Taking the payment cuts would force some practices to refuse Medicare patients and, in turn, force Congress to decide on how to pay for the SGR repeal. However, that proposition went unanswered. A permanent repeal could cost as much as $180 billion, yet no one is willing to shoulder the costs.
“We have never opposed a patch before,” said American College of Physicians spokesman David Kinsman. “This is unique because we’re so close. This time, we have bicameral and bipartisan support for permanent reform.”
Senator Reid explained that an inability to arrive at an agreeable permanent SGR fix resulted in the decision. “I hope it’s our last patch,” he said.
Grouping other policy measures, such as ICD-10 and the 2-midnight rule, has also raised concerns.
“We’re generally not pleased that something as critical as ICD-10 becomes fodder for other legislation,” said Russell P. Branzell, FCHIME, CHCIO, president and CEO of the College of Healthcare Information Management Executives. “That’s an area that needs to either stand on its own and/or be discussed on its own. When you start combining all these programs together, none of them can be looked at on their own merits and concerns.”
Established in 1997, the SGR system has determined how much physicians are paid in relation to the projected growth of the economy. Since 2003, Congress has passed yearly “doc fox” bills as a way to compensate doctors’ Medicare reimbursements as healthcare costs continually rise.
Around the Web
Senate OKs SGR patch, delays ICD-10 [Fierce Healthcare]
Docs Would Accept Payment Cuts to Force Permanent SGR Repeal [Fierce Healthcare]
Senate Delays ICD-10, Patches SGR [Healthcare Payer News]
For 17th Time in 11 Years, Congress Delays Medicare Reimbursement Cuts as Senate Passes ‘Doc Fix’ [The Washington Post]
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More